Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys
Year: 2000
Type: article
Source: Experimental Neurology
Authors: Tomoyuki Kanda, Michael J. Jackson, Lance A. Smith, Ronald K.B. Pearce, Joji Nakamura, Hiroshi Kase, Yoshihisa Kuwana, Peter Jenner
Institution: King's College London
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2030108063
